Cited by 341Cytokine Signaling Pathways and InteractionsHead and Neck Cancer StudiesNF-κB Signaling Pathways

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Open access

Leong, Paul L., Andrews, Genevieve A., Johnson, Daniel E., Dyer, Kevin F., Xi, Sichuan, Mai, Jeffrey C., Robbins, Paul D., Gadiparthi, Seshu, Burke, Nancy A., Watkins, Simon F., Grandis, Jennifer Rubin·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0534764100PMC PMC153061

Open this paper in CoChat — free account

Abstract

The transcription factor signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers including squamous cell carcinoma of the head and neck (SCCHN). Previous investigations have demonstrated that activated Stat3 contributes to a loss of growth control and transformation. To investigate the therapeutic potential of blocking Stat3 in cancer cells, we developed a transcription factor decoy to selectively abrogate activated Stat3. The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the Stat3 response element within the c-fos promoter. The Stat3 decoy bound specifically to activated Stat3 and blocked binding of Stat3 to a radiolabeled Stat3 binding element. By contrast, a mutated version of the decoy that differed by only a single base pair did not bind the activated Stat3 protein. Treatment of head and neck cancer cells with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression, but did not decrease the proliferation of normal oral keratinocytes. Thus, disruption of activated Stat3 by using a transcription factor decoy approach may serve as a novel therapeutic strategy for cancers characterized by constitutive Stat3 activation.

Integrity signals

Registry

Crossref · 10.1073/pnas.0534764100

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
STATs in oncogenesis
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.
Sadowski, H., Shuai, K., Darnell, J., & Gilman, M. (1993) · Science · doi:10.1126/science.8397445 · Cited by 682
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W. C., Leonhardt, E. A., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 661

Show all 47 references

Research works printed but not linked: 8

T Kijima, H Niwa, R A Steinman, S D Drenning, W E Gooding, A L Wentzel, J Rubin Grandis Cell Growth Differ 13, 355–362 (2002).
B L Riser, R Mitra, D Perry, V Dixit, J Varani Cancer Res 49, 6123–6129 (1989).
D S Heo, C Snyderman, S M Gollin, S Pan, E Walker, R Deka, E L Barnes, J T Johnson, R B Herberman, T L Whiteside Cancer Res 49, 5167–5175 (1989).
H W Sharma, R Narayanan Anticancer Res 16, 589–596 (1996).
H W Sharma, J R Perez, K Higgins-Sochaski, R Hsiao, R Narayanan Anticancer Res 16, 61–69 (1996).
Y Sawa, R Morishita, K Suzuki, K Kagisaki, Y Kaneda, K Maeda, K Kadoba, H Matsuda Circulation 96,(Suppl.), II-280–II-284, ; discussion, II-285. (1997).
G Niu, R Heller, R Catlett-Falcone, D Coppola, M Jaroszeski, W Dalton, R Jove, H Yu Cancer Res 59, 5059–5063 (1999).
M Masuda, M Suzui, R Yasumatu, T Nakashima, Y Kuratomi, K Azuma, K Tomita, S Komiyama, I B Weinstein Cancer Res 62, 3351–3355 (2002).

Sorted by citations

STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Self-citation
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Zhou, J., Wulfkuhle, J. D., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, E., & Zhang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702596104 · Cited by 704
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Soni, K. S., Desale, S. S., & Bronich, T. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 714
Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation
Radaeva, S., Sun, R., Pan, H., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 638
Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L. M., & O’Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 578
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Sansone, P., & Bromberg, J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8907 · Cited by 518
The potential and controversy of targeting STAT family members in cancer
Verhoeven, Y., Tilborghs, S., Jacobs, J., De Waele, J., Quatannens, D., Deben, C., Prenen, H., Pauwels, P., Trinh, X. B., Wouters, A., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.002 · Cited by 409
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 441
Targeting STAT3 in cancer: how successful are we?
Yue, P.-B., & Turkson, J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802565791 · Cited by 425
Role of STAT3 in Cancer Metastasis and Translational Advances
Kamran, M. Z., Patil, P. S., & Gude, R. P. (2013) · BioMed Research International · doi:10.1155/2013/421821 · Cited by 397
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 377
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
Chan, K. S., Sano, S., Kiguchi, K., Anders, J., Komazawa, N., Takeda, J., & DiGiovanni, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21032 · Cited by 355
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
de la Iglesia, N., Konopka, G., Puram, S. V., Chan, J. A., Bachoo, R. M., You, M. J., Levy, D. E., DePinho, R. A., & Bonni, A. (2008) · Genes & Development · doi:10.1101/gad.1606508 · Cited by 336
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“Nucleic acid–based drugs, including decoy oligonucleotides and, perhaps, G-quartet oligonucleotides, have been identified that inhibit STAT3-mediated gene expression and inhibit growth of different cancer cell lines (Leong et al., 2003; Lewis et al., 2008; Sun et al., 2008; Shen et al., 2009; Zhang et al., 2013b; Liu…”
Background
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
Sen, M., Thomas, S. M., Kim, S., Yeh, J. I., Ferris, R. L., Johnson, J. T., Duvvuri, U., Lee, J., Sahu, N., Joyce, S., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0191 · Cited by 313
Self-citation
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling
Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308
STAT proteins as novel targets for cancer drug discovery
Turkson, J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.409 · Cited by 297
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q. (2014) · Cancers · doi:10.3390/cancers6020926 · Cited by 288
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Hu, Y., Dong, Z., & Liu, K. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02949-5 · Cited by 307
Emerging avenues linking inflammation and cancer
Kundu, J. K., & Surh, Y. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.035 · Cited by 272
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
Bradshaw, A., Wickremsekera, A., Tan, S. T., Peng, L., Davis, P. F., & Itinteang, T. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00021 · Cited by 277
Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications
Huang, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2313 · Cited by 251
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Regis, G., Pensa, S., Boselli, D., Novelli, F., & Poli, V. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.004 · Cited by 241
Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas
Brantley, E. C., & Benveniste, E. N. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2180 · Cited by 239
STAT3 as a therapeutic target in head and neck cancer
Leeman‐Neill, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 225
Self-citation
Leptin-mediated Cell Survival Signaling in Hippocampal Neurons Mediated by JAK STAT3 and Mitochondrial Stabilization
Guo, Z., Jiang, H., Xu, X. Z. S., Duan, W., & Mattson, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703753200 · Cited by 202
The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations
Geiger, J. L., Grandis, J. R., & Bauman, J. E. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.022 · Cited by 193
Self-citation
The Role of STAT3 in Non-Small Cell Lung Cancer
Harada, D., Takigawa, N., & Kiura, K. (2014) · Cancers · doi:10.3390/cancers6020708 · Cited by 195
The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
Abou-Ghazal, M. K., Yang, D. S., Qiao, W., Reina-Ortiz, C., Wei, J., Kong, L., Fuller, G. N., Hiraoka, N., Priebe, W., Sawaya, R. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1329 · Cited by 195
STAT inhibitors for cancer therapy
Furqan, M., Akinleye, A., Mukhi, N., Mittal, V., Chen, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-90 · Cited by 191
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
Lai, S. Y., & Johnson, F. M. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.04.001 · Cited by 193
Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells
Baek, S. H., Ko, J., Lee, H., Jung, J., Kong, M., Lee, J.-W., Lee, J., Chinnathambi, A., Zayed, M., Alharbi, S. A., et al. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.02.011 · Cited by 184
Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
Sano, S., Chan, K. S., & DiGiovanni, J. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.016 · Cited by 182
STAT3 pathway in cancers: Past, present, and future
Wang, H., Man, Q., Huo, F., Gao, X., Lin, H., Li, S.-R., Wang, J., Su, F., Cai, L., Shi, Y., et al. (2022) · MedComm · doi:10.1002/mco2.124 · Cited by 175
Signal Transducers and Activators of Transcription (STATs): Novel Targets of Chemopreventive and Chemotherapeutic Drugs
Klampfer, L. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056491 · Cited by 169
Stat3 activation in human endometrial and cervical cancers
Chen, C.-L., Hsieh, F.-C., Lieblein, J., Brown, J., Chan, C., Wallace, J. A., Cheng, G., Hall, B. M., & Lin, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603597 · Cited by 171
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy
Xi, S., Gooding, W. E., & Grandis, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 172
Self-citation
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J. L., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Sen, M., Joyce, S., Panahandeh, M., Li, C., Thomas, S. M., Maxwell, J., Wang, L., Gooding, W. E., Johnson, D. E., & Grandis, J. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0792 · Cited by 158
Self-citation
Targeting Transcription Factors for Cancer Gene Therapy
Libermann, T. A., & Zerbini, L. F. (2006) · Current Gene Therapy · doi:10.2174/156652306775515501 · Cited by 153
Mitochondrial Stat3, the need for design thinking
Yang, R., & Rincon, M. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15153 · Cited by 147
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe, J., Liu, J., & Zhang, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.006 · Cited by 144
STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
Lee, C., & Cheung, S. (2019) · Cancers · doi:10.3390/cancers11111646 · Cited by 148
G-Quartet Oligonucleotides
Jing, N., Li, Y., Xiong, W., Sha, W., Jing, L., & Tweardy, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4041 · Cited by 132
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
Lim, C. P., Phan, T.-T., Lim, I. J., & Cao, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209531 · Cited by 135
STAT3 inhibitors for cancer therapy
Fagard, R., Metelev, V., Souissi, I., & Baran‐Marszak, F. (2013) · JAK-STAT · doi:10.4161/jkst.22882 · Cited by 131
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo
Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., Kalvakolanu, D. V., Kopecko, D. J., Zhao, X., & Xu, D.-Q. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0148 · Cited by 131
STAT3 Activation Regulates Growth, Inflammation, and Vascularization in a Mouse Model of Gastric Tumorigenesis
Judd, L. M., Bredin, K., Kalantzis, A., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.018 · Cited by 131
STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
Kim, J., Patel, M. A., Ruzevick, J., Jackson, C. M., & Lim, M. K. (2014) · Cancers · doi:10.3390/cancers6010376 · Cited by 128
The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
Zemskova, M., Sahakian, E., Bashkirova, S., & Lilly, M. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709479200 · Cited by 127
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Haftchenary, S., Luchman, H. A., Jouk, A. O., Veloso, A. J., Page, B. D. G., Cheng, X. R., Dawson, S. S., Grinshtein, N., Shahani, V. M., Kerman, K., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4003138 · Cited by 126
Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects
Fischer, P., & Hilfiker‐Kleiner, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.1 · Cited by 126
RETRACTED: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
Agarwal, C., Tyagi, A., Kaur, M., & Agarwal, R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm042 · Cited by 128
Retracted
Drugging the undruggable: Transcription therapy for cancer
Yan, C., & Higgins, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.11.002 · Cited by 126
New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
Chen, L. F., Cohen, E. E. W., & Grandis, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2318 · Cited by 120
Self-citation
STAT3 Regulation of Glioblastoma Pathogenesis
de la Iglesia, N., Puram, S. V., & Bonni, A. (2009) · Current Molecular Medicine · doi:10.2174/156652409788488739 · Cited by 117
Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo
Yin, D., Li, Y., Lin, H., Guo, B., Du, Y., Li, X., Jia, H., Zhao, X., Tang, J., & Zhang, L. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/10/105102 · Cited by 116
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas
Lee, T., Yeh, J., Waes, C. V., & Chen, Z. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0069 · Cited by 115
Many good reasons to have STAT3 in the heart
Hilfiker-Kleiner, D., Hilfiker, A., & Drexler, H. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.003 · Cited by 115
Progress towards the development of SH2 domain inhibitors
Kraskouskaya, D., Duodu, E., Arpin, C. C., & Gunning, P. T. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35449k · Cited by 115
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Zhang, X., Zhang, J., Wang, L., Wei, H., & Tian, Z. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-149 · Cited by 115
A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas
Lee, T., Yeh, J., Friedman, J., Yan, B., Yang, X., Yeh, N. T., Waes, C. V., & Chen, Z. (2008) · International Journal of Cancer · doi:10.1002/ijc.23324 · Cited by 110
Phase I study of OPB ‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
Ogura, M., Uchida, T., Terui, Y., Hayakawa, F., Kobayashi, Y., Taniwaki, M., Takamatsu, Y., Naoe, T., Tobinai, K., Munakata, W., et al. (2015) · Cancer Science · doi:10.1111/cas.12683 · Cited by 110
Bcl-2 Orchestrates a Cross-talk between Endothelial and Tumor Cells that Promotes Tumor Growth
Kaneko, T., Zhang, Z., Mantellini, M. G., Karl, E., Zeitlin, B. D., Verhaegen, M. E., Soengas, M. S., Lingen, M. W., Strieter, R. M., Núñez, G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1497 · Cited by 107
The JAK/STAT signaling cascade in gastric carcinoma (Review)
Khanna, P., Chua, P. J., Bay, B., & Baeg, G. H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3160 · Cited by 105
Targeting STAT3 in cancer and autoimmune diseases
Gharibi, T., Babaloo, Z., Hosseini, A., Abdollahpour‐Alitappeh, M., Hashemi, V., Marofi, F., Nejati‐Koshki, K., & Baradaran, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173107 · Cited by 105
Prognostic significance of nuclear pSTAT3 in oral cancer
Macha, M. A., Matta, A., Kaur, J., Chauhan, S. S., Thakar, A., Shukla, N. K., Gupta, S. D., & Ralhan, R. (2010) · Head & Neck · doi:10.1002/hed.21468 · Cited by 105
Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene
Williams, V., Brichler, S., Radjef, N., Lebon, P., Goffard, A., Hober, D., Fagard, R., Kremsdorf, D., Dény, P., & Gordien, E. (2009) · Journal of General Virology · doi:10.1099/vir.0.011239-0 · Cited by 104
Signal transducer and activator of transcription 3 inhibitors: a patent review
Page, B. D. G., Ball, D. P., & Gunning, P. T. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.539205 · Cited by 103
Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival
Chen, C.-L., Cen, L., Kohout, J., Hutzen, B., Chan, C., Hsieh, F.-C., Loy, A., Huang, V., Cheng, G., & Lin, J. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-78 · Cited by 125
Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation
Wheeler, S., Suzuki, S., Thomas, S. M., Sen, M., Leeman‐Neill, R. J., Chiosea, S. I., Kuan, C.-T., Bigner, D. D., Gooding, W. E., Lai, S. Y., et al. (2010) · Oncogene · doi:10.1038/onc.2009.279 · Cited by 102
Self-citation
Signal Transducer and Activator of Transcription 3 Is a Key Regulator of Keratinocyte Survival and Proliferation following UV Irradiation
Sano, S., Chan, K. S., Kira, M., Kataoka, K., Takagi, S., Tarutani, M., Itami, S., Kiguchi, K., Yokoi, M., Sugasawa, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4359 · Cited by 102
Endothelial Interleukin-6 Defines the Tumorigenic Potential of Primary Human Cancer Stem Cells
Krishnamurthy, S., Warner, K. A., Dong, Z., Imai, A., Nör, C., Ward, B. B., Helman, J. I., Taichman, R. S., Bellile, E. L., McCauley, L. K., et al. (2014) · Stem Cells · doi:10.1002/stem.1793 · Cited by 102
Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma
Adachi, M., Cui, C., Dodge, C. T., Bhayani, M. K., & Lai, S. Y. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.006 · Cited by 97
RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells
Lee, S. O., Lou, W., Qureshi, K. M., Mehraein‐Ghomi, F., Trump, D. L., & Gao, A. C. (2004) · The Prostate · doi:10.1002/pros.20072 · Cited by 97
Identification of STAT3 as a specific substrate of breast tumor kinase
Liu, L., Gao, Y., Qiu, H., Miller, W. T., Poli, V., & Reich, N. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209501 · Cited by 97
Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides
Weerasinghe, P., Garcia, G., Zhu, Q., Yuan, P., Feng, L., Mao, L., & Jing, N. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.1.129 · Cited by 95
Polymer beacons for luminescence and magnetic resonance imaging of DNA delivery
Bryson, J. M., Fichter, K. M., Chu, W., Lee, J. H., Li, J., Madsen, L. A., McLendon, P. M., & Reineke, T. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904860106 · Cited by 95
17-Hydroxy-jolkinolide B Inhibits Signal Transducers and Activators of Transcription 3 Signaling by Covalently Cross-Linking Janus Kinases and Induces Apoptosis of Human Cancer Cells
Wang, Y., Ma, X., Yan, S., Shen, S., Zhu, H., Gu, Y. J., Wang, H., Qin, G., & Yu, Q. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0462 · Cited by 94
STAT3 signaling in ovarian cancer: a potential therapeutic target
Liang, R., Chen, X., Chen, L., Wan, F., Chen, K.-H., Sun, Y., & Zhu, X. (2019) · Journal of Cancer · doi:10.7150/jca.35011 · Cited by 91
The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition
Desrivières, S., Kunz, C., Barash, I., Vafaizadeh, V., Borghouts, C., & Groner, B. (2006) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9014-4 · Cited by 91
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
Zhang, Q., Hossain, D. M. S., Duttagupta, P. A., Moreira, D., Zhao, X., Won, H., Buettner, R., Nechaev, S., Majka, M., Zhang, B., et al. (2016) · Blood · doi:10.1182/blood-2015-08-665604 · Cited by 90
Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth
Zhang, L., Gao, L., Li, Y., Lin, G., Shao, Y., Ji, K., Yu, H., Hu, J., Kalvakolanu, D. V., Kopecko, D. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1176 · Cited by 89
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer
Jing, N., Zhu, Q., Yuan, P., Li, Y., Mao, L., & Tweardy, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0302 · Cited by 88
Design, synthesis, and studies of small molecule STAT3 inhibitors
Bhasin, D. K., Cisek, K. K., Pandharkar, T., Regan, N., Li, C., Pandit, B., Lin, J., & Li, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.031 · Cited by 88
Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis
Xi, S., Dyer, K. F., Kimak, M. A., Zhang, Q. H., Gooding, W. E., Chaillet, J. R., Chai, R. L., Ferrell, R. E., Zamboni, B. A., Hunt, J. L., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj020 · Cited by 87
Self-citation
Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis
Karamouzis, M. V., Konstantinopoulos, P. A., & Papavassiliou, A. G. (2007) · Cell Research · doi:10.1038/cr.2007.10 · Cited by 88
STAT Signaling in Glioma Cells
Swiatek-Machado, K., & Kaminska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_10 · Cited by 86
miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression
Sun, X., Zhang, J., Hou, Z., Han, Q., Zhang, C., & Tian, Z. (2015) · Cell Cycle · doi:10.4161/15384101.2014.977112 · Cited by 87
IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain
Zhang, L., Badgwell, D. B., Bevers, J. J., Schlessinger, K., Murray, P. J., Levy, D. E., & Watowich, S. S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9137-3 · Cited by 89
Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
Sun, X., Zhang, J., Wang, L., & Tian, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.009 · Cited by 80
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis
Huang, C., & Xie, K. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.01.003 · Cited by 80
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
Dorritie, K. A., McCubrey, J. A., & Johnson, D. E. (2013) · Leukemia · doi:10.1038/leu.2013.192 · Cited by 84
Self-citation
Signal Transducer and Activator of Transcription 3 (STAT3): A Promising Target for Anticancer Therapy
Masciocchi, D., Gelain, A., Villa, S., Meneghetti, F., & Barlocco, D. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.22 · Cited by 80
Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells
Gao, L., Xu, D.-Q., Wen, L., Zhang, X., Shao, Y., & Zhao, X. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00053.x · Cited by 78
Stat3 is required for the development of skin cancer
Pedranzini, L., Leitch, A., & Bromberg, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22800 · Cited by 78

Authors: Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., & Grandis, J. R.
Affiliations: University of Pittsburgh (US)
Departments of Otolaryngology, Medicine, Pharmacology, Molecular Genetics and Biochemistry, and Cell Biology and Physiology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15260
ORCID: Johnson, Daniel E.
Robbins, Paul D.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2003-03-14
Volume: 100
Issue: 7
Pages: 4138-4143
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0534764100
PMC: PMC153061
OpenAlex: W2143812692
Cited by: 340
References: 47
Citations by year: 2026: 5 · 2025: 4 · 2024: 13 · 2023: 11 · 2022: 6 · 2021: 8 · 2020: 13 · 2019: 14 · 2018: 10 · 2017: 3 · 2016: 8 · 2015: 20 · 2014: 16 · 2013: 23 · 2012: 25
FWCI: 7.21
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
American Academy of Otolaryngology-Head and Neck Surgery
National Institutes of Health
National Cancer Institute (CA77308, R01CA077308)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT3, transcription factor decoy, head and neck squamous cell carcinoma, c-fos promoter, constitutive STAT3 activation, tumor cell proliferation, oral keratinocytes
MeSH terms: Carcinoma, Squamous Cell, Cell Division, DNA-Binding Proteins, Head and Neck Neoplasms, Humans, Luciferases, Tumor Cells, Cultured, Trans-Activators, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Oligodeoxyribonucleotides, Antisense, STAT3 Transcription Factor, bcl-X Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks